S.A. Mason’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
1,947
+4
+0.2% +$4.05K 0.67% 38
2025
Q4
$2.09M Hold
1,943
0.83% 26
2025
Q3
$1.48M Hold
1,943
0.65% 36
2025
Q2
$1.51M Sell
1,943
-1
-0.1% -$777 0.73% 34
2025
Q1
$1.61M Hold
1,944
0.85% 28
2024
Q4
$1.5M Hold
1,944
0.79% 32
2024
Q3
$1.72M Hold
1,944
0.91% 21
2024
Q2
$1.76M Buy
1,944
+137
+8% +$110K 1% 21
2024
Q1
$1.41M Buy
1,807
+21
+1% +$14.9K 0.85% 29
2023
Q4
$1.04M Buy
1,786
+35
+2% +$20.4K 0.7% 38
2023
Q3
$941K Hold
1,751
0.68% 39
2023
Q2
$601K Hold
1,751
0.44% 63
2023
Q1
$601K Hold
1,751
0.44% 63
2022
Q4
$641K Hold
1,751
0.48% 60
2022
Q3
$566K Hold
1,751
0.45% 55
2022
Q2
$568K Hold
1,751
0.41% 63
2022
Q1
$501K Hold
1,751
0.31% 88
2021
Q4
$484K Hold
1,751
0.29% 93
2021
Q3
$405K Hold
1,751
0.27% 101
2021
Q2
$402K Hold
1,751
0.28% 98
2021
Q1
$327K Hold
1,751
0.24% 112
2020
Q4
$296K Sell
1,751
-30
-2% -$4.48K 0.25% 107
2020
Q3
$264K Buy
1,781
+30
+2% +$4.64K 0.25% 105
2020
Q2
$287K Sell
1,751
-300
-15% -$46K 0.3% 92
2020
Q1
$285K Hold
2,051
0.35% 81
2019
Q4
$270K Buy
+2,051
New +$238K 0.26% 108

Other funds holding LLY

S.A. Mason's LLY Position: Q1 2026 in Review

S.A. Mason increased its Eli Lilly (LLY) stake by 0.21% in Q1 2026, buying an estimated $4.05K and bringing the position to 1,947 shares worth $1.79M. The position accounts for 0.67% of the portfolio, ranked #38.

S.A. Mason first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.09M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • S.A. Mason held 1,947 shares of Eli Lilly worth $1.79M as of Q1 2026.
  • S.A. Mason bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.67% of S.A. Mason's portfolio in Q1 2026, its #38 holding.
  • S.A. Mason first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • S.A. Mason's Eli Lilly position peaked at $2.09M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on S.A. Mason's 13F filing for Q1 2026, filed 27 Apr 2026.